Serum Institute CEO Hails WHO’s Approval Of Covovax For Emergency Use

Serum Institute of India (SII) CEO Adar Poonawalla on Friday hailed WHO’s approval for emergency use of the Covovax vaccine “as yet another milestone” in the fight against Covid-19. The World Health Organization (WHO) on Friday listed the Covovax as the
http://dlvr.it/SFcDGz